Patents by Inventor Alfred Sandrock

Alfred Sandrock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Treating Multiple Sclerosis and Preserving and/or Increasing Myelin Content
    Publication number: 20140163100
    Abstract: Methods of treating multiple sclerosis in a subject, including: reducing the frequency of relapse, reducing the annualized relapse rate, reducing the risk of disability progression, reducing the number of new or newly enlarging T2 lesions, reducing the number of gadolinium lesions; and methods of preserving/increasing myelin content in a subject having multiple sclerosis; by daily administering a composition containing a fumarate, such as dimethyl fumarate or monomethyl fumarate, to the subject.
    Type: Application
    Filed: May 25, 2012
    Publication date: June 12, 2014
    Applicant: Biogen IDEC MA Inc.
    Inventors: Katherine Dawson, Gilmore O'Neill, Alfred Sandrock
  • Therapies for Chronic Inflammatory Demyelinating Polyneuropathy Using Interferon-Beta
    Publication number: 20120058083
    Abstract: The present invention provides methods for the treatment, and pharmaceuticals for the use in the treatment, of mammalian subjects having, or at risk of developing, chronic demyelinating neuropathies, e.g., CIDP. The methods involve the administration of IFN-? therapeutics.
    Type: Application
    Filed: November 11, 2010
    Publication date: March 8, 2012
    Applicant: Biogen Idec MA Inc.
    Inventor: Alfred Sandrock
  • TREATMENT FOR MULTIPLE SCLEROSIS
    Publication number: 20090202527
    Abstract: Methods of treating multiple sclerosis and other disorders are disclosed.
    Type: Application
    Filed: November 18, 2005
    Publication date: August 13, 2009
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Michael Panzara, Alfred Sandrock
  • Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-ss
    Publication number: 20060182715
    Abstract: The present invention provides methods for the treatment, and pharmaceuticals for the use in the treatment, of mammalian subjects having, or at risk of developing, chronic demyelinating neuropathies, e.g., CIDP. The methods involve the administration of IFN-? therapeutics.
    Type: Application
    Filed: September 26, 2003
    Publication date: August 17, 2006
    Inventor: Alfred Sandrock